Serum RANKL levels in Chinese patients with ankylosing spondylitis: a meta-analysis
Abstract Objective We aimed to determine the association between serum receptor activator of nuclear factor-kappa B ligand (sRANKL) levels and ankylosing spondylitis (AS) in Chinese patients. Methods The PubMed, Cochrane Library, Embase, Chinese Biomedical Database, Web of Science, China National Kn...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2021-10-01
|
| Series: | Journal of Orthopaedic Surgery and Research |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13018-021-02721-x |
| _version_ | 1811306940964274176 |
|---|---|
| author | Feifei Ni Yanchao Zhang Yi Peng Xiaoxiao Peng Jianjun Li |
| author_facet | Feifei Ni Yanchao Zhang Yi Peng Xiaoxiao Peng Jianjun Li |
| author_sort | Feifei Ni |
| collection | DOAJ |
| description | Abstract Objective We aimed to determine the association between serum receptor activator of nuclear factor-kappa B ligand (sRANKL) levels and ankylosing spondylitis (AS) in Chinese patients. Methods The PubMed, Cochrane Library, Embase, Chinese Biomedical Database, Web of Science, China National Knowledge Infrastructure, VIP, and Wan Fang databases were searched for studies conducted before October 1, 2020, without language restrictions. STATA version 12.0 and Revman version 5.3 were used to analyze the data. The standard mean differences (SMDs) and corresponding 95% confidence intervals (95% CIs) were calculated. Results Twelve clinical case–control studies, including 585 patients with AS and 423 healthy controls, were included. The combined SMD for sRANKL suggested that the sRANKL level was significantly higher in Chinese patients with AS than in healthy controls (SMD: 3.27, 95% CI 2.11–4.43, P < 0.00001). Serum RANKL-related factor osteoprotegerin (OPG) levels (SMD: 0.86, 95% CI 0.09–1.64, P < 0.03) were lower in the Chinese patients with AS than in healthy controls, and the RANKL/OPG ratio (SMD = 1.05, 95% CI 0.64–1.46, P < 0.00001) in Chinese patients with AS was approximately the same as that of healthy controls. Subgroup analysis indicated that patients from North and South China had higher sRANKL levels than controls; the sRANKL levels of patients from South China were higher in the subgroup with a Bath Ankylosing Spondylitis Functional Index (BASFI) of > 4 than those of patients in other subgroups. In terms of duration, patients with AS for > 8 years had higher sRANKL levels than health controls. Other subgroup analyses were conducted by region, language, source of control, age, and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI). In these subgroups, the sRANKL levels were significantly higher in the patients with AS than in healthy controls. The BASFI and BASDAI were sources of heterogeneity. Conclusions The sRANKL levels are higher in Chinese patients with AS, especially among those from South China. sRANKL levels may be positively correlated with the pathogenesis of AS among Chinese patients. |
| first_indexed | 2024-04-13T08:54:41Z |
| format | Article |
| id | doaj.art-a8f7d97f3ea24fb1a1085687d21a6695 |
| institution | Directory Open Access Journal |
| issn | 1749-799X |
| language | English |
| last_indexed | 2024-04-13T08:54:41Z |
| publishDate | 2021-10-01 |
| publisher | BMC |
| record_format | Article |
| series | Journal of Orthopaedic Surgery and Research |
| spelling | doaj.art-a8f7d97f3ea24fb1a1085687d21a66952022-12-22T02:53:20ZengBMCJournal of Orthopaedic Surgery and Research1749-799X2021-10-0116111310.1186/s13018-021-02721-xSerum RANKL levels in Chinese patients with ankylosing spondylitis: a meta-analysisFeifei Ni0Yanchao Zhang1Yi Peng2Xiaoxiao Peng3Jianjun Li4Department of Orthopaedics, Shengjing Hospital of China Medical UniversityDepartment of Orthopedics, Tianjin Baodi Hospital/Baodi Clinical College of Tianjin Medical UniversityDepartment of Urological, Nantong University Danyang Teaching HospitalDaxing Teaching Hospital of Capital Medical UniversityDepartment of Orthopaedics, Shengjing Hospital of China Medical UniversityAbstract Objective We aimed to determine the association between serum receptor activator of nuclear factor-kappa B ligand (sRANKL) levels and ankylosing spondylitis (AS) in Chinese patients. Methods The PubMed, Cochrane Library, Embase, Chinese Biomedical Database, Web of Science, China National Knowledge Infrastructure, VIP, and Wan Fang databases were searched for studies conducted before October 1, 2020, without language restrictions. STATA version 12.0 and Revman version 5.3 were used to analyze the data. The standard mean differences (SMDs) and corresponding 95% confidence intervals (95% CIs) were calculated. Results Twelve clinical case–control studies, including 585 patients with AS and 423 healthy controls, were included. The combined SMD for sRANKL suggested that the sRANKL level was significantly higher in Chinese patients with AS than in healthy controls (SMD: 3.27, 95% CI 2.11–4.43, P < 0.00001). Serum RANKL-related factor osteoprotegerin (OPG) levels (SMD: 0.86, 95% CI 0.09–1.64, P < 0.03) were lower in the Chinese patients with AS than in healthy controls, and the RANKL/OPG ratio (SMD = 1.05, 95% CI 0.64–1.46, P < 0.00001) in Chinese patients with AS was approximately the same as that of healthy controls. Subgroup analysis indicated that patients from North and South China had higher sRANKL levels than controls; the sRANKL levels of patients from South China were higher in the subgroup with a Bath Ankylosing Spondylitis Functional Index (BASFI) of > 4 than those of patients in other subgroups. In terms of duration, patients with AS for > 8 years had higher sRANKL levels than health controls. Other subgroup analyses were conducted by region, language, source of control, age, and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI). In these subgroups, the sRANKL levels were significantly higher in the patients with AS than in healthy controls. The BASFI and BASDAI were sources of heterogeneity. Conclusions The sRANKL levels are higher in Chinese patients with AS, especially among those from South China. sRANKL levels may be positively correlated with the pathogenesis of AS among Chinese patients.https://doi.org/10.1186/s13018-021-02721-xRANKLAnkylosing spondylitisPathogenesisMeta-analysisChina |
| spellingShingle | Feifei Ni Yanchao Zhang Yi Peng Xiaoxiao Peng Jianjun Li Serum RANKL levels in Chinese patients with ankylosing spondylitis: a meta-analysis Journal of Orthopaedic Surgery and Research RANKL Ankylosing spondylitis Pathogenesis Meta-analysis China |
| title | Serum RANKL levels in Chinese patients with ankylosing spondylitis: a meta-analysis |
| title_full | Serum RANKL levels in Chinese patients with ankylosing spondylitis: a meta-analysis |
| title_fullStr | Serum RANKL levels in Chinese patients with ankylosing spondylitis: a meta-analysis |
| title_full_unstemmed | Serum RANKL levels in Chinese patients with ankylosing spondylitis: a meta-analysis |
| title_short | Serum RANKL levels in Chinese patients with ankylosing spondylitis: a meta-analysis |
| title_sort | serum rankl levels in chinese patients with ankylosing spondylitis a meta analysis |
| topic | RANKL Ankylosing spondylitis Pathogenesis Meta-analysis China |
| url | https://doi.org/10.1186/s13018-021-02721-x |
| work_keys_str_mv | AT feifeini serumrankllevelsinchinesepatientswithankylosingspondylitisametaanalysis AT yanchaozhang serumrankllevelsinchinesepatientswithankylosingspondylitisametaanalysis AT yipeng serumrankllevelsinchinesepatientswithankylosingspondylitisametaanalysis AT xiaoxiaopeng serumrankllevelsinchinesepatientswithankylosingspondylitisametaanalysis AT jianjunli serumrankllevelsinchinesepatientswithankylosingspondylitisametaanalysis |